Xuezheng Li

3.3k citations
95 papers · 2.6k indexed · 1 hit paper · h-index 35

Xuezheng Li

95 papers receiving 2.6k citations

Hit Papers

Transcriptome analysis of axillary buds in low phosphorus...552024202620251020304050

Peers

Xuezheng Li
Comparison fields: 5 of 154
  • Pharmacology 258
  • Obstetrics and Gynecology 156
  • Biochemistry 103
  • Cancer Research 259
  • Complementary and alternative medicine 124
Replace Shuang Guan with:
Shuang Guan China
Feijun Luo China
İbrahim Hanifi Özercan Türkiye
Yifei Chen China
Ali Khodadadi Iran
Chao Sun China
Sekaran Muniandy Malaysia
Guoqing Liu China
Junaid Khan Pakistan
Xiaofang Liu China
Xuezheng Li relative to Shuang Guan China Shuang Guan's profile →
Citations per field
00.5×3.4×
Shuang Guan · 1×
Citations per year

Countries citing papers authored by Xuezheng Li

Since Specialization
Citations

This map shows the geographic impact of Xuezheng Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuezheng Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuezheng Li more than expected).

Fields of papers citing papers by Xuezheng Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuezheng Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuezheng Li. The network helps show where Xuezheng Li may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Xuezheng Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xuezheng Li Line = papers co-authored together Xuezheng Li links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20247
3 20242
4 20245
5 20232
6 20235
7 20231
8 20226
9 202116
10 201928
11 201920
12 20197
13
Studies on the Chemical Components and Biological Activities of the genus of Caragana
20182
14 201850
15 201750
16 201647
17 201267
18 201215
19 201146
20 20041

About Xuezheng Li

Xuezheng Li is a scholar working on Pharmacology, Cancer Research and Biochemistry, having authored 95 papers that have together received 2.6k indexed citations. Recurring topics across this work include Natural product bioactivities and synthesis (16 papers), Phytochemistry and Biological Activities (9 papers), Electronic Packaging and Soldering Technologies (7 papers), Air Quality and Health Impacts (6 papers), Intermetallics and Advanced Alloy Properties (5 papers), Tuberculosis Research and Epidemiology (5 papers), Plant biochemistry and biosynthesis (5 papers) and Phytochemicals and Antioxidant Activities (5 papers). The work is most often cited by research in Pharmacology (258 citations), Obstetrics and Gynecology (156 citations) and Biochemistry (103 citations). Xuezheng Li has collaborated with scholars based in China, Japan and United States. Frequent co-authors include Peixin Yang, Cheng Xu, Yong Ma, Seikou Nakamura, Masayuki Yoshikawa, Hisashi Matsuda, E. Albert Reece, Hongbo Weng, Ning Li and Chunliu Mi. Their work appears in journals such as Nature Communications, Diabetes and Bioresource Technology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026